Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer.

Journal: BJR open
Published Date: May 21, 2025

Abstract

Lung cancer is the second most commonly diagnosed cancer worldwide. In the present era of targeted therapy for various lung cancer mutations, it is essential to be aware of the imaging correlates of various lung cancer mutations on contrast enhanced computed tomography of thorax. In this article, we have discussed the imaging patterns of various types of lung cancer including different mutations and also comprehensively reviewed the imaging recommendations (National Comprehensive Cancer Network [NCCN], European Society of Medical Oncology [ESMO] and American Society of Clinical Oncology [ASCO]) and management guidelines of lung cancer (non-small cell, small cell and other neuroendocrine tumours). We have also discussed guidelines for screening, diagnosis, staging (recent 9th edition tumour node metastasis [TNM]), treatment response evaluation, and follow up. Role of interventional radiology in the treatment of primary lung cancer, lung metastasis, and management of posttreatment complications, have also been described in detail in this article. In addition, current status of artificial intelligence in lung cancer has also been briefly discussed.

Authors

  • Nivedita Chakrabarty
    Department of Radiodiagnosis, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Abhishek Mahajan
    Department of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool L7 8YA, UK.
  • Nitin Shetty
    Department of Radiodiagnosis and Interventional Radiology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Naveen Mummudi
    Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Devyani Niyogi
    Department of Surgical Oncology, Tata Memorial Centre, Tata memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Falguni Hota
    Department of Interventional Radiology, Tata Memorial Centre, Tata memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Deepak Dabkara
    Department of Medical Oncology, Tata Medical Center, Rajarhat, Kolkata 700 160, West Bengal, India.
  • Reefath Jebraj
    Department of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Nilendu Purandare
    Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
  • Vanita Noronha
    Department of Medical Oncology, Tata Memorial Center, Mumbai 400012, India.
  • Ashu Bhalla
    Department of Radiology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India.
  • Kumar Prabhash
    Department of Medical Oncology, Tata Memorial Hospital, Mumbai 400012, India.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals